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Abstract
The neutrophil gelatinase-associated lipocalin 2 (LCN2) is a critical inflammatory mediator persistently induced during
endotoxemia, contributing to tubular damage and kidney failure. The intracellular process responsible for persistent
induction of LCN2 by bacterial endotoxin Lipopolysaccharide (LPS) is not well understood. Using primary kidney fibroblasts,
we observed that LPS-induced LCN2 expression requires a coupled circuit involving an early transient phase of AP-1 path
and a late persistent phase of C/EBPd path, both of which are dependent upon the interleukin 1 receptor associated kinase
1 (IRAK-1). Using immunoprecipitation analysis we observed transient binding of AP-1 to the promoters of both TNFa and C/
ebpd. On the other hand, we only observed persistent binding of C/EBPd to its own promoter but not on TNFa. Blockage of
new protein synthesis using cyclohexamide significantly reduced the expression of C/EBPd as well as LCN2. By chromatin
immunoprecipitation analyses, we demonstrated that LPS recruited C/EBPd to the Lcn2 promoter in WT, but not IRAK-1
deficient fibroblasts. A differential equation-based computational model captured the dynamic circuit leading to the
persistent induction of LCN2. In vivo, we observed elevated levels of LCN2 in kidneys harvested from LPS-injected WT mice
as compared to IRAK-1 deficient mice. Taken together, this study has identified an integrated intracellular network involved
in the persistent induction of LCN2 by LPS.
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Introduction
Initially identified in neutrophils as a gelatinase-associated small
protein [1], LCN2 was recognized as an innate defense molecule by
sequestering and depleting iron-containing siderophores and
curbing bacterial growth [2]. Recent studies reveal that LCN2
can be potently induced by inflammatory stimulants and widely
expressed in vital organs and tissues such as kidney, heart, and brain
[3,4,5,6]. Elevated level of LCN2 in kidney is a well-recognized
marker for both chronic kidney diseases, reflecting the extent of
kidney damage [7,8]. LCN2 is not only a marker, but also a key
contributor of kidney disease, as reflected by the alleviation of
chronic kidney damage in mice with Lcn2 gene deletion [6].
Bacterial endotoxin (lipopolysaccharide-LPS) is a potent inducer
of LCN2 [9,10,11]. Elevated levels of endotoxin are seen in both
acute and chronic conditions. Acute endotoxemia leads to septic
shock and multi-organ damages including acute kidney failure
[12]. In contrast, chronic endotoxemia associated with obesity,
aging, and other adverse health conditions can lead to persistent
inflammatory complications and chronic diseases [11,13,14].
LCN2 levels persist during both acute and chronic phases of
kidney damage, and may serve as a key propagating factor for
chronic kidney disease [6]. However, the molecular mechanism
underlying the persistent expression of LCN2 is not well
understood.
Studies using other inflammatory stimulants such as IL-17 and
IL-1b indicate that the induction of LCN2 requires multiple
transcription factors including AP-1 and C/EBPd [9,15]. AP-1
activation by LPS is transient and responsible for the transient
induction of pro-inflammatory mediators [16]. On a separate
report, C/EBPd was implicated in propagating the persistent
activation of TLR4 pathway [17].
Based on these observations, we examined the molecular circuit
underlying the persistent induction of LCN2 by LPS in kidney
fibroblasts. We identified that IRAK-1, a key TLR4 intracellular
signaling component, is involved in coordinating both the transient
activation of AP-1, as well as the persistent activation of C/EBPd,
which are collectively responsible for the sustained expression of
LCN2. We further performed a differential equation-based
computational modeling, which complemented our experimental
data and revealed a dynamic intracellular signaling circuit
responsible for the persistent induction of LCN2 by LPS.
Materials and Methods
Reagents
LPS (Escherichia coli 0111:B4) and Cycloheximide were obtained
from Sigma Aldrich. Anti-LCN2 antibody was purchased from
R&D Systems. Anti- IkBa antibody was purchased from Cell
Signaling. Anti-Lamin B (ab-16048) was purchased from Abcam.
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GAPDH (FL-335), anti-IRAK-1 (F-4), and anti-b-actin (C-4)
antibodies were from Santa Cruz Biotechnology.
Kidney Fibroblast cultures
Both WT and IRAK-1
2/2 C57/BL/6 mice were housed and
bred in the Derring Hall Animal Facility in compliance with
approved Animal Care and Use Committee protocols at Virginia
Polytechnic Institute and State University. Murine kidney fibro-
blasts were isolated as previously described [18]. Fibroblast cells
were grown in 50:50 DMEM/F12 #10-092-CV (Mediatech
TM,
Inc., VA) supplemented with 10% FBS #SH30071.03 (Hyclone
TM)
and 1% Penicillin/Streptomycin at 37uC with 5% CO2.
Real time RT-PCR (qRT-PCR)
Total RNAs were harvested from murine kidney fibroblasts
treated with or without LPS using TrizolH Reagent (Invitrogen)
according to the manufacturer’s protocol. cDNAs were generated
using the High Capacity cDNA Reverse Transcription Kit (Applied
BioSystems
TM, Foster, CA). Real-time PCR analyses were
performed using the iQ SybrH Green Supermix (BioRad
TM
Laboratories, Hercules, CA) on an IQ5 thermocycler (BioRad).
The relative levels of transcripts were calculated using the DDCt
method using GAPDH as the internal control. The relative levels of
mRNAfrom the untreated samples wereadjusted to 1 and served as
the basal control value. The following primers were used perform
qRT-PCR: mouse LCN2 forward: 59- TTT CAC CCG CTT TGC
CAA GT-39, reverse: 59-GTC TCT GCG CAT CCC AGT CA-39;
mouse C/ebpd forward: 59-ACT TCA GCG CCT ACA TTG ACT
CCA-39, reverse: 59-TGT TGA AGA GGT CGG CGA AGA
GTT-39; mouse GAPDH forward: 59-AAC TTT GGC ATT GTG
GAA GGG CTC-39, reverse: 59- GGA AGA GTG GGA GTT
GCT GTT GA-39; mouse TNFa forward: 59-AGC CGA TGG
GTT GTA CCT TGT CTA-39, reverse: 59-TGA GAT AGC AAA
TCG GCT GAC GGT-39; mouse Il-6 forward: 59-ATC CAG
TTG CCT TCT TGG GAC TGA-39, reverse: 59- TAA GCC
TCC GAC TTG TGA AGT GGT-39; mouse SOCS1 forward: 59-
AGT CGC CAA CGG AAC TGC TTC TT-39, reverse: 59-ACG
TAG TGC TCC AGC AGC TCG AAA-39; and mouse ATF3
forward: 59-TCA AGG AAG AGC TGA GAT TCG CCA-39,
reverse: 59-GTT TCG ACA CTT GGC AGC AGC AAT-39.
Western Blot Analysis
Isolation of whole cell, cytoplasmic, and nuclear lysates were
performed as described previously [19]. Briefly, fibroblasts were
lysed on ice using lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10% Triton X-100, 10 mM KCl, 0.5 mM EDTA,
0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride,
1 ug/mL leupeptin, 1 ug/mL pepstatin) for 30 minutes. Samples
were centrifuged at 5000 rpm for 10 minutes at 4uC. The
supernatants were saved as the cytoplasmic extract and the
pelleted nuclei were re-suspend and lysed in a high salt buffer
(20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 0.4 M NaCl, 0.2 mM
EDTA, 0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluo-
ride) on ice for 30 minutes. The samples were then centrifuged at
12,000 RPM for 20 minutes at 4uC and supernatant kept as the
nuclear extract. Protein samples were analyzed by Western Blot as
described before. Images were quantified with Fujifilm Multi
Gauge software normalized against b actin, GAPDH, or Lamin B.
Chromatin Immunoprecipitation (ChIP) assays
Protein and chromatin from treated cells were cross-linked using
1% formaldehyde solution in complete media for 15 minutes with
gentle rocking every 3 minutes at room temperature. Cells were
washed twice with cold PBS and treated with a glycine solution for
5 minutes to stop the cross-linking reaction. The cells were then
lysed in an ice cold buffer containing SDS and protease inhibitor
cocktail. The samples were then subject to sonication in an ice
water bath to shear the chromatin for 6 minutes (30 seconds on
and 30 seconds off). The sheared chromatin was processed using
Chip-IT Express Kit #53008 from Active Motif
TM. The immune-
precipitated chromatin was analyzed by PCR using primer pairs
that span the promoter regions of either Lcn2, C/ebpd, and Tnfa.
The primer sequences are as follows: mouse pLcn2 forward: 59-
TGA CCC ACA AGC AGT GCC CTG T-39, reverse: 59-ACT
TGG CAA GAT TTC TGT CCC-39; mouse pC/ebpd forward:
59-ACA AAC AGG AAG GAG GGA AG-39, reverse: 59-TCC
AAG TTG GGC TGT CA-39; and mouse pTnfa forward: 59-
AGG AGA TTC CTT GAT GCC TGG GT-39, reverse: 59-TTT
CTG TTC TCC CTC CTG GCT AGT-39.
Figure 1. LPS stimulation induces a persistent induction of
LCN2 in kidney fibroblasts. (A) LPS (100 ng/ml) induces a transient
induction of Tnfa mRNA. (B) LPS (100 ng/ml) induces a persistent
induction of Lcn2 mRNA Transcript levels were measured by qRT-PCR as
described above. The results are expressed as means +/2 standard
deviation performed in triplicate. (C) LCN2 protein levels persist after
24 hours of LPS stimulation. The levels of LCN2 were visualized by
western blot.
doi:10.1371/journal.pone.0034633.g001
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Female IRAK-1
2/2 and WT C57/BL/6 mice of 12 weeks old
received intraperitoneal injections with 25 mg/kg of LPS. Six
hours after the injection, mice were sacrificed and the whole
kidney tissue was harvested for subsequent mRNA analysis by real
time RT-PCR and protein analyses by Western blot.
Computational analysis
A differential-equation based computational modeling is
performed as previously described [20]. A detailed description of
the modeling approach is provided in the supplementary
document accompanying this manuscript.
Statistical Analysis
Data significance was determined using the student t-test. P-
values less than 0.05 were considered statistically significant as
indicated by an asterisk (*).
Results
LPS induces persistent expression of LCN2 in kidney
fibroblasts in an IRAK-1 dependent fashion
We first compared the expression profiles of selected inflam-
matory genes in fibroblasts stimulated with LPS. As shown in
Figure 1A, the induction of Tnfa message by LPS was transient,
peaked at the 2 hour time point post challenge, and returned to
basal values at the 16 hour time point. In contrast, the expression
of Lcn2 mRNA persisted throughout the course of LPS treatment
(Fig. 1B). Because IRAK-1 is one of the key downstream
components of TLR4 pathway, we evaluated whether IRAK-1
is involved in both the transient induction of Tnfa and persistent
induction of Lcn2 message. As shown in Figure 1A and 1B, the
inductions of both Tnfa and Lcn2 were significantly reduced in
IRAK-1 deficient kidney fibroblasts. We also confirmed the
induction of LCN2 protein in wild type (WT) cells by LPS
(Fig. 1C).
LPS induces transient activation of AP-1 and persistent
induction of C/EBPd in kidney fibroblasts
To determine the potential mechanism for the persistent
induction of LCN2 in kidney fibroblasts by LPS, we examined
the activation status of relevant transcription factors including
NFkB, AP-1 and C/EBPd. As shown in Figure 2A, LPS treatment
caused no apparent decrease in the levels of Ikba in WT
fibroblasts, indicating a lack of robust NFkB activation by LPS in
kidney fibroblasts. Further supporting this claim, we observed that
the residue nuclear p65/RelA remained constant following LPS
treatment (Fig. 2B). In contrast, we observed a rapid yet transient
induction of AP-1/c-Jun. Nuclear levels of AP-1/c-Jun was
induced by LPS, reached its peak level by 60 to 120 minutes,
and decreased at 240 minutes after LPS challenge (Fig. 2C). C/
EBPd, on the other hand, was elevated after 24 hr of LPS
Figure 2. LPS induces transient activation of AP-1 and persistent induction of C/EBPd in kidney fibroblasts. WT fibroblasts were treated
with LPS (100 ng/ml) for the indicated time periods. (A) LPS fails to significantly induce IkBa degradation. Whole cell lysates were harvested and
analyzed by Western blot using an IkBa specific antibody. (B) LPS fails to significantly induce p65 nuclear translocation in kidney fibroblasts. Nuclear
cell lysates were harvested and analyzed by Western blot using an anti-p65 antibody. (C) LPS induces the active translocation of AP-1/c-Jun. Nuclear
lysates were harvested and analyzed by Western blot. (D&E) LPS induces a persistent increase of C/EBPd protein. Whole cell lysates were harvested
and analyzed by Western blot. (F) LPS significantly induces the expression of C/ebpd dependent upon IRAK-1. WT and IRAK-1 deficient cells were
treated with LPS for indicated time period. Message levels of C/ebpd were determined by RT-PCR. n=3; *P,0.05.
doi:10.1371/journal.pone.0034633.g002
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not give rise to quantitative result, we performed RT-PCR analysis
of C/ebpd expression induced by LPS. As shown in Figure 2F, LPS
significantly induced the expression of C/ebpd, and such induction
is dependent on IRAK-1.
Based on above observation and previous studies, we propose
that a coupled step-wise process may lead to the persistent
activation and induction of C/EBPd. LPS may first induce an
initial C/EPBd expression primarily through a transient activation
of AP-1 and residue NFkB in the nucleus [21]. Subsequently,
newly synthesized C/EBPd can auto-induce its own expression
and contribute to a steady induction of C/EBPd [17] and its
downstream target gene LCN2. To test this hypothesis, we
performed Chromatin immunoprecipitation (ChIP) analysis to
determine the recruitment of c-Jun and C/EBPd to the promoter
of C/ebpd. As shown in Figure 3, LPS transiently increased the
recruitment of c-Jun to the promoter of C/ebpd (Figure 3A) and
Tnfa (Figure 3B), peaking at 4 hr for C/ebpd and 1 hr for Tnfa
promoter, and dropping off at the 8 hr time point. In contrast,
increased recruitment of C/EBPd at the 8 hr time point was
evident on the promoter of C/ebpd, but not Tnfa.
Both De novo synthesis and subsequent activation of C/
EBPd is required for the expression of LCN2
To further confirm that de novo synthesis of C/EBPd is involved
in LPS-induced LCN2 expression, we applied cycloheximide
(CHX), a known protein synthesis inhibitor, to the culture
medium. As shown in Figure 4A, CHX significantly reduced
LPS-mediated induction of Lcn2 message, suggesting that new
protein synthesis is required for the induction of LCN2 gene
expression. In contrast, CHX has no inhibitory effect on LPS-
mediated expression of C/ebpd message (Figure 4B). This is in
agreement with a previous finding that the expression of C/EBPd
and its subsequent transcriptional activation are two separate
events controlled by two distinct upstream processes [21]. To
further confirm the role of C/EBPd in LPS induced expression of
Lcn2, we examined the recruitment of C/EBPd to the promoter of
Lcn2 following LPS challenge. As shown in Figure 4C, LPS
dramatically prolonged the elevated recruitment of C/EBPd to the
Lcn2 promoter in WT cells.
The lack of inducible negative regulators contributes to
prolonged expression of LCN2 in kidney fibroblasts upon
LPS stimulation
Through the classical NFkB pathway, LPS is known to induce
negative regulators that subsequently turn off the expression of
pro-inflammatory genes. Among the negative regulators, SOCS1
suppresses the upstream LPS signaling pathway by inhibiting
IRAK-1 [22]. On the other hand, ATF3 is shown to compete
and suppress the activity of C/EBPd [17,23]. Given the fact that
we did not observe noticeable activation of the NFkB pathway,
we hypothesize that LPS may not be able to induce related
negative regulators in kidney fibroblasts. Indeed, we demonstrat-
ed that LPS failed to induce the expression of Socs 1 and Atf 3
(Fig. 5A). As a consequence, we observed that there was no
apparent degradation of IRAK-1 protein in kidney fibroblasts
following a 4 hr LPS treatment (Fig. 5B). Taken together, our
data indicate that LPS treatment in kidney fibroblasts failed to
induce negative regulators that modulate the persistent activation
of C/EBPd, leading to a sustained induction of its downstream
gene Lcn2.
In vivo induction of LCN2 expression in an IRAK-1
dependent fashion
To test the in vivo relevance of our finding, we examined the
expression of LCN2 in kidney tissues from WT and IRAK-1
deficient mice following LPS challenge. As shown in Figure 6, LPS
injection induced significant induction of Lcn2 messages as well as
LCN2 proteins in kidney tissues harvested from LPS-injected WT
mice. In contrast, the levels of Lcn2 messages were significantly
lower in kidneys harvested from IRAK-1 deficient mice injected
with LPS.
Computational analyses of the molecular circuit
responsible for the persistent induction of LCN2 in
kidney fibroblasts
We further fit our experimental data into a differential equation
based computation model (Fig. 7). This model takes into
consideration of the positive feedback loop involving C/EBPd
that helps to maintain a sustained expression of LCN2.
This model is based on a coarse-grained TLR4-signaling
network that highlights the core pathways controlling the
induction of LCN2. As is shown in Figure 7A, this signaling
circuit is composed of both an early-phase module with transient
response and a late-phase module with persistent response. Each
module can be viewed as an information processor that receives
inputs from upstream signals, and generate outputs that regulate
downstream response. The two modules are connected. The
transcription of C/EBPd is dependent on AP-1/c-Jun, and serves
as the core of the late-phase module.
Figure 3. LPS induces transient recruitment of c-Jun to the
promoters of Tnfa and C/ebpd, and induces prolonged recruit-
ment of C/EBPd to the promoter of C/ebpd. WT kidney fibroblasts
were treated with or without LPS for a time course. Nuclear lysates were
then subjected to ChIP analysis to examine relative binding to the
promoter of C/ebpd (A) or Tnfa (B).
doi:10.1371/journal.pone.0034633.g003
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ODE describes the change of a molecular species in the relative
level as a function of time. Parameters such as mRNA degradation
rates are estimated based on our data or from existing literatures.
Other parameters such as activating threshold k and relative
weights K are estimated using genetic algorithm of least square
regression (MATLABH 2009b, the MathWorks, Natick, MI). All
parameters are listed in Table 2.
As is shown in Figure 7B, our computational model based on
the proposed signaling circuitry fits well with the experimental
data. The model reveals that the essential requirement of the
biphasic dynamics of C/EBPd and LCN2 is the proper timing of
the two consecutive modules. The immediate yet transient
induction in c-Jun explains the first pulse in C/EBPd, when the
early-phase module dominates the dynamics of the system. As
soon as c-Jun decays, the late-phase module relays the signal and
an auto-regulation of C/EBPd gives rise to the persistent induction
of both C/EBPd and LCN2. IKKe plays an important role in
ensuring the correct timing of the second module. Experimentally,
it was shown that IKKe activates the activity of C/EBPd, therefore
the auto-regulation of C/EBPd is IKKe-dependent (21).
Taken together, our computational simulation based on the
intracellular signaling circuitry identified in this report fitted well
with the experimental data, capturing the dynamic intracellular
circuits that give rise to transient induction of TNFa and persistent
induction of LCN2.
Discussion
In this report, we have identified that LPS can induce a
persistent expression of LCN2 in kidney fibroblasts. The
intracellular signaling circuit responsible for the persistent
induction of LCN2 involves dynamic interaction among AP-1
and C/EBPd. An early phase of a transient AP-1 activation helps
to usher in a late phase of C/EBPd activation. IRAK-1 is
responsible for the propagation of both phases necessary for the
persistent induction of LCN2.
Our study shed light on the dynamic and functional circuitry
within cells when challenged with bacterial endotoxin. Although
empirical knowledge reckons that integrated intracellular circuits
instead of linear cascades are more capable of interpreting and
responding properly to environmental cues including LPS, almost
all existing studies have adopted conventional approaches in
defining the signaling cascades downstream of LPS and TLR4
receptors [24]. To this regard, a large number of signaling
molecules and pathways have been discovered that can be
activated by LPS [25]. However, how these signals are properly
integrated and give rise to distinct cellular responses is not clear.
Figure 4. Lcn2 transcription requires new protein synthesis, but C/ebpd does not. C/EBPd is recruited to the promoter of LCN2 upon
LPS stimulation in an IRAK-1 dependent manner. (A) Cyclohexamide, a protein synthesis inhibitor, blocks Lcn2 transcription upon LPS
stimulation. (B) The induction of C/ebpd does not require new protein synthesis. (B) Wild-type kidney fibroblasts were untreated (DMSO) or pretreated
with cyclohexamide 5 ug/mL for 1 hour. Immediately following pretreatment, the cells were stimulated with or without LPS for 4 hours. Transcripts
were quantitated using qRT-PCR and standardized using Gapdh as the internal loading control. Each experiment was performed in triplicate. *P,0.05
(C) The recruitment of C/EBPd to the promoter of LCN2 upon LPS stimulation depends upon IRAK-1. Nuclear lysates were subject to ChIP analysis
using a C/EBPd specific antibody. The arrow points to the specific amplification signal for C/ebpd promoter. The * sign indicates a non-specific
amplification.
doi:10.1371/journal.pone.0034633.g004
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area of LPS signaling within host cells, and reveals an integrated
circuit that couples a transient activation of AP-1 with a sustained
activation of C/EBPd.
Our effort is made possible by the integrated approach
combining experimental tests and computational analyses. Taken
into consideration of the experimental data, we have employed a
differential equation-based approach to analyze time-dependent
activation of AP-1 and C/EBPd, as well as expression of Tnfa and
Lcn2. As a consequence, genes primarily under the control of AP-1
such as Tnfa experience a transient pattern of expression. The
expression of C/ebpd, on the other hand, is initially activated by
AP-1, and subsequently sustained by its own auto-activation
[17,21]. Due to the transient nature of AP-1 activation, we
observed a transient dip in the expression of C/ebpd (around the
4 hr time point). Subsequent self-activation of C/EBPd then
sustains the continued expression of C/ebpd and its downstream
gene Lcn2. A detailed computational analysis can be seen in the
supplementary material.
It is likely that there will be significant perturbations as well as
additional connections surrounding this circuit in different cell
types. Consequently, this may allow distinct outcomes in different
cell types in response to bacterial endotoxin. For example, the
expression of C/EBPd in macrophages induced by LPS eventually
subsides, due to a novel negative feedback initiated by ATF3 [17].
In contrast, we observed that LPS failed to induce Atf3 in kidney
fibroblasts, which may explain the sustained expression and
activation of C/EBPd. This may due to the fact that fibroblasts
are less sensitive to the LPS challenge as compared to macrophages.
Indeed, our recent study indicates that a much lower LPS dose
(,50 pg/ml) induces a persistent activation of C/EBPd in
macrophages [26], similar to the effect seen in this study using
fibroblasts with a high dose LPS. Further supporting this claim, we
observed that IRAK-1 is relatively stable in kidney fibroblasts
treated with 100 ng/ml LPS. In contrast, it was observed that
100 ng/ml LPS causes IRAK-1 degradation in macrophages,
which can dampen the signals leading to C/EBPd activation,
leading to LPS tolerance [27]. Further studies employing systems
biology approach are clearly warranted to clarify the differential
sensing mechanisms of LPS signal strength in different cell types.
On a separate note, the integrated systems approach will likely
explain the complex phenotypes such as LPS priming and tolerance
exhibited in cells treated with either a low or a high dose LPS.
Our findings bear significant clinical implication during the
pathogenesis of chronic and persistent inflammatory diseases.
Local tissues and fibroblasts encountering bacterial endotoxin may
Figure 5. Socs1 and Atf3, negative regulators of TLR4 signaling,
are not induced and IRAK-1 remains intact upon LPS stimula-
tion in kidney fibroblasts. (A) The expressions of Socs1 and Atf3
were not induced after stimulation with LPS. Wild-type kidney
fibroblasts were either untreated or treated with 100 ng/mL LPS for
4, 6, or 10 hours. Socs1, Atf3, and Il-6 transcripts were measured by real
time RT-PCR assays and standardized against Gapdh levels. Each
experiment was performed in triplicate. Data is depicted as means +/2
standard deviation. (B) LPS does not cause the degradation of IRAK-1.
Wild-type kidney fibroblasts were either untreated or treated with
100 ng/mL LPS for either 2 or 4 hours. Whole cell lysates were
harvested and analyzed by Western blot with IRAK-1 specific antibodies.
doi:10.1371/journal.pone.0034633.g005
Figure 6. Loss of IRAK-1 causes decreased expression of Lcn2
mRNA and protein in vivo. WT and IRAK-1
2/2 C57/BL/6 female mice
of 12 weeks old (6 each) were intraperitoneally injected with either
30 mg/kg of LPS or PBS for 6 hours. (A) Kidney tissues were extracted
and subject to RNA extraction. Lcn2 transcripts were measured by qRT-
PCR assays and standardized against their respective controls (mice
receiving PBS injections). Data is depicted as three separate mice (both
WT and IRAK-1
2/2). *P,0.05 (B) Protein lysates were extracted from the
kidney tissues and subjected to Western blot. Blots were analyzed using
LCN2 specific antibodies. The same blot was probed with b-actin as a
loading control.
doi:10.1371/journal.pone.0034633.g006
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dampening mechanism. As a consequence, inflammatory media-
tors such as LCN2 may accumulate and lead to chronic tissue
damages including kidney failure. Strategies targeting at this
functional circuit may hold promise in designing therapeutic
strategies to combat chronic inflammatory diseases.
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Figure 7. Computational simulation captures the dynamic
features of the experimental data. (A) The network motif
responsible for the transient induction of Tnfa and the persistent
induction of Lcn2. (B) Computational simulation of the transient
induction of Tnfa and persistent induction of Lcn2. Circles denote
actual experimental data. Lines represent computational simulations.
doi:10.1371/journal.pone.0034633.g007
Table 1. Ordinary Differential Equations used in the model.
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Subscripts of parameters denote the direction of regulations. For example, k61
represents the threshold for c-Jun (x1) to activate C/EBPd (x6).
doi:10.1371/journal.pone.0034633.t001
Table 2. List of the estimated parameter values.
Parameter Value Description
b1 2:1|10{2 Degradation rate of x1 (based on Western Blot
data)
b2 1:0|10{3 Degradation rate of x2
b3 1:5|10{2 Degradation rate of x3
b4 5:0|10{2 Degradation rate of x4 (based on RT-PCR data)
b5 1:1|10{3 Degradation rate of x5
b6 1:1|10{2 Degradation rate of x6, based on (2)
b7 2:9|10{3 Degradation rate of x7 (based on RT-PCR data)
K1 2.1 Weighted factor
K4 11.0 Weighted factor
K61 8.6 Weighted factor
K66 1.3 Weighted factor
K7 1.2 Weighted factor
k12 1:2|10{1 Threshold of x2 to inhibit x1
k23 1:5|10{2 Threshold of x3 to activate x2
k41 1.7 Threshold of x1 to activate x4
k61 1.4 Threshold of x1 to activate x6
k66 1:7|10{1 Threshold of x6 to activate x6 (auto-regulation)
k65 4:6|10{1 Threshold of x5 to activate x6
k76 3:0|10{1 Threshold of x6 to activate x7
n12 4 Coefficient of nonlinearity for x2 to inhibit x1
n23 4 Coefficient of nonlinearity for x3 to activate x2
n41 4 Coefficient of nonlinearity for x1 to activate x4
n61 4 Coefficient of nonlinearity for x1 to activate x6
n66 4 Coefficient of nonlinearity for x6 to activate x6
n65 4 Coefficient of nonlinearity for x5 to activate x6
n76 4 Coefficient of nonlinearity for x6 to activate x7
Parameters such as mRNA degradation rates are estimated based on our data or
from existing literatures. Values of other parameters such as activation/
inhibition threshold k and relative weights K are estimated to fit in the time
course data by genetic algorithm of least square regression. Degradation rates
are in the unit of/min. Activation/inhibition thresholds, nonlinearity coefficients
and relative weights for multiple inputs are non-dimensionalized.
doi:10.1371/journal.pone.0034633.t002
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